Pharma Focus Asia
KP - Sustainable Packaging Solutions

Takeda to Build Manufacturing Plant with More than US$106mn in Germany

Introduction:

Takeda Pharmaceuticals Company Limited (Takeda) announced that the company will invest more than US$106.35 million (£100 Million) to build Dengue vaccine Manufacturing Plant in Singen, Germany.

Features:

Takeda plans to meet unmet needs in dengue prevention through Dengue Vaccine Candidate (TAK-003).

TAK-003 is Takeda’s tetravalent dengue vaccine candidate, which is based on a live-attenuated dengue serotype 2 viruses (DENV-2). It provides genetic backbone for all four vaccine viruses.

To support the protection of populations and individuals who suffer from dengue virus, Takeda develops dengue vaccine. Investment on this manufacturing plant strengthens Takeda’s strong support for global vaccine strategy in general, and dengue in particular.

Unmet medical needs can be reduced and this Dengue Vaccine Manufacturing Plant will provide millions of people with access to a medicine.

Currently there are five different kinds of dengue vaccine candidates that are undergoing clinical trials, including live-attenuated vaccines, subunit, DNA and purified inactivated vaccine candidates.

Specifications:

NameTakeda Pharmaceuticals Company Limited (Takeda)
LocationSingen, Germany
TypeManufacturing Plant
Estimated CostUS$106.35 million (£100 Million)
Parties InvolvedTakeda
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?